ISDA

Deposition Date 2017-04-11

Release Date 2017-07-05

Last Version Date 2023-10-04

Entry Detail

PDB ID:

5VGO

Keywords:

Transferase/Transferase Inhibitor

Title:

Bruton's tyrosine kinase (BTK) with compound G-744

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.62 Å

R-Value Free:

0.18

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 61

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Tyrosine-protein kinase BTK
Gene (Uniprot):BTK
Chain IDs:A
Chain Length:271
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q06187 Pfam ID:PF07714 EC:2.7.10.2

Ligand Molecules

9B1

GOL

PG0

SO4

Primary Citation

Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties.

Wang, X, Barbosa, J, Blomgren, P, Bremer, M.C, Chen, J, Crawford, J.J, Deng, W, Dong, L, Eigenbrot, C, Gallion, S, Hau, J, Hu, H, Johnson, A.R, Katewa, A, Kropf, J.E, Lee, S.H, Liu, L, Lubach, J.W, Macaluso, J, Maciejewski, P, Mitchell, S.A, Ortwine, D.F, DiPaolo, J, Reif, K, Scheerens, H, Schmitt, A, Wong, H, Xiong, J.M, Xu, J, Zhao, Z, Zhou, F, Currie, K.S, Young, W.B.Show

ACS Med Chem Lett 8 608 613 (2017)

PMID: 28626519 DOI: 10.1021/acsmedchemlett.7b00103

Abstact

In our continued effort to discover and develop best-in-class Bruton's tyrosine kinase (Btk) inhibitors for the treatment of B-cell lymphomas, rheumatoid arthritis, and systemic lupus erythematosus, we devised a series of novel tricyclic compounds that improved upon the druglike properties of our previous chemical matter. Compounds exemplified by G-744 are highly potent, selective for Btk, metabolically stable, well tolerated, and efficacious in an animal model of arthritis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures